Melatonin attenuates antipsychotic metabolic effects: an eight-week randomized, double-blind, parallel-group, placebo-controlled clinical trial. - Wikidata - wikimedia - TriplyDB

Melatonin attenuates antipsychotic metabolic effects: an eight-week randomized, double-blind, parallel-group, placebo-controlled clinical trial.

Melatonin attenuates antipsychotic metabolic effects: an eight-week randomized, double-blind, parallel-group, placebo-controlled clinical trial.

http://www.wikidata.org/entity/Q50654258

about

Update on the safety of second generation antipsychotics in youths: a call for collaboration among paediatricians and child psychiatrists Future Directions for Pharmacotherapies for Treatment-resistant Bipolar Disorder Nutritional interventions for the adjunctive treatment of schizophrenia: a brief review Managing cardiovascular disease risk in patients treated with antipsychotics: a multidisciplinary approach New targets for rapid antidepressant action.Bipolar disorder: role of immune-inflammatory cytokines, oxidative and nitrosative stress and tryptophan catabolites.Melatonin, mitochondria, and the metabolic syndrome.The Circadian System: A Regulatory Feedback Network of Periphery and Brain.BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment.Can melatonin prevent or improve metabolic side effects during antipsychotic treatments?Olanzapine-induced early cardiovascular effects are mediated by the biological clock and prevented by melatonin.Seasonal pattern in bipolar disorders and cardio-vascular risk factors: A study from the FACE-BD cohort.Clozapine-Induced Cardiovascular Side Effects and Autonomic Dysfunction: A Systematic Review.Mitochondrial Agents for Bipolar Disorder.Reduced fat mass and increased lean mass in response to 1 year of melatonin treatment in postmenopausal women: A randomized placebo-controlled trial.Melatonin for Atypical Antipsychotic-Induced Metabolic Adverse Effects: A Meta-Analysis of Randomized Controlled Trials.Does Melatonin and Melatonin Agonists Improve the Metabolic Side Effects of Atypical Antipsychotics?: A Systematic Review and Meta-analysis of Randomized Controlled Trials Pharmacologic Treatment Options for Insomnia in Patients with Schizophrenia Potential Crosstalk between Fructose and Melatonin: A New Role of Melatonin-Inhibiting the Metabolic Effects of Fructose

P2860

Q26747123-0CFFE415-FC55-4409-8251-3B095329F90C Q26782989-B84AD975-1A98-417C-8C3A-7418EC631FB2 Q28248117-5B481B5A-2C19-4B09-B96A-810696E78174 Q34464293-8954B885-8238-4A84-9E91-EF37AC607A0B Q34507177-D281BCA5-A11A-409C-8020-55F0BE2091A6 Q38332353-C86E54ED-8CDF-4787-A039-F1669F2DD473 Q38618827-C72B37B5-151A-4DFF-B3C0-183B728A8E30 Q38800342-09FB417F-9491-4E61-B553-DEE3EC473687 Q38826206-88D7F327-9510-45E2-B5A1-9D8F3011E858 Q41441546-B843BBBF-8316-4017-9D71-3216F2F37003 Q47793695-F51DAE4B-59B7-4E85-974D-2EE051C6D47B Q47877921-20DFF088-BD87-45F1-BECF-62557C7E9F54 Q52579281-DC597EE9-5267-4369-BA6A-7BD7B9BAAEE7 Q52621890-20BEB1F7-5C2C-499B-942E-21BE29B4C26D Q53357194-8EF24D28-843A-4564-9C51-3D44F15D5D19 Q55239758-B34B9118-58FF-4DCC-AEFD-0BB0EE943ABB Q58781420-2A9D6A89-0600-4B0D-A460-B3C418A987B4 Q58788087-1361C40A-621A-411B-963F-1C46E14391AB Q58805847-27375CC2-A63D-4B0C-8BEB-7BE98094E02F

P2860

Melatonin attenuates antipsychotic metabolic effects: an eight-week randomized, double-blind, parallel-group, placebo-controlled clinical trial.

http://www.wikidata.org/entity/Q50654258

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Melatonin attenuates antipsych ...... ebo-controlled clinical trial.

@en

Melatonin attenuates antipsych ...... ebo-controlled clinical trial.

@nl

type

label

Melatonin attenuates antipsych ...... ebo-controlled clinical trial.

@en

Melatonin attenuates antipsych ...... ebo-controlled clinical trial.

@nl

prefLabel

Melatonin attenuates antipsych ...... ebo-controlled clinical trial.

@en

Melatonin attenuates antipsych ...... ebo-controlled clinical trial.

@nl

P1433

Q50654258-0999614F-5094-4FB1-8D53-35AEE6BAF072

P1476

Q50654258-78ABFBFC-51A2-4BC4-A826-EA2C261C6B16

P2093

Q50654258-1CA1376E-8CF4-4366-A99D-6BAFCCF19C20

Q50654258-33F20186-2C91-4EFC-9566-3C74FD909DDE

Q50654258-353FD558-1540-4CA6-8036-103CC2B5F91B

Q50654258-6C73E556-B144-4442-8E07-87DF02040477

Q50654258-7B978621-8FBA-4FCA-B15A-8E19A5F394EE

Q50654258-853A384E-83CF-4AE9-B24B-645C4DF7F9FA

Q50654258-8D69B93C-1FCA-44CC-B02F-82EFE87362C0

Q50654258-9524CE4F-E20E-4AEA-B406-F1A2AF277227

Q50654258-AC4DC9AE-BE5B-41FC-A183-15941B10F8A8

Q50654258-F1156613-447B-4121-A396-CE4FCB257FF2

P2860

Q50654258-00DB3629-8E03-4928-BBBA-9629A401F577

Q50654258-0448A059-1F45-4FBE-A317-03D8D6169721

Q50654258-151D0BD3-5490-4EBD-B7B9-735B9FB78F0C

Q50654258-16E770C5-309E-4C62-8549-D274471B4072

Q50654258-1E4B9645-3534-408B-9C67-E751FD4882B5

Q50654258-236175C9-63DA-440E-AA67-84E66A7AF9BB

Q50654258-25B6D45E-60DE-4840-ABD1-2D890EEE2A9E

Q50654258-34A97D11-E134-4050-BB0D-3173D2394CC9

Q50654258-39B8EB1F-0B73-4C00-8210-FFFFFD3C3CAE

Q50654258-3B346650-D25F-46A3-A213-D33F2742FEEE

P304

Q50654258-4446C952-5B0C-48F9-A444-D6F56B166A40

P31

Q50654258-ABCEF5B3-42D8-4E0F-8C18-3FCB14D3BDB8

P356

Q50654258-F3B8B070-1C22-471B-BA15-9C3F6DD9BB2E

P433

Q50654258-07859865-04AC-479E-AB4D-AC46AB207A53

P478

Q50654258-B8D067E4-0669-4AD2-99F5-B0579709FE75

P577

Q50654258-B393A559-5861-4EE4-8DFC-520BE4D2E249

P698

Q50654258-9778EC12-8F57-4631-A0A9-FCA62DA39C0B

P921

Q50654258-0B4B984B-DE1B-4606-8D07-5115DAA07838

Q50654258-4F4D68B0-9FCB-4F3E-A03F-6DE332826EB2

P356

P1433

Bipolar Disorders

P1476

Melatonin attenuates antipsych ...... ebo-controlled clinical trial.

@en

P2093

Ana Fresán-Orellana

http://www.w3.org/2001/XMLSchema#string

Carlos Berlanga

http://www.w3.org/2001/XMLSchema#string

Claudia Becerra-Palars

http://www.w3.org/2001/XMLSchema#string

Dení Alvarez-Icaza González

http://www.w3.org/2001/XMLSchema#string

Francisco Romo-Nava

http://www.w3.org/2001/XMLSchema#string

Gerhard Heinze

http://www.w3.org/2001/XMLSchema#string

Julia Moreno

http://www.w3.org/2001/XMLSchema#string

Martha P Ontiveros Uribe

http://www.w3.org/2001/XMLSchema#string

Ricardo Saracco Alvarez

http://www.w3.org/2001/XMLSchema#string

Ruud M Buijs

http://www.w3.org/2001/XMLSchema#string

P2860

Alterations to melanocortinergic, GABAergic and cannabinoid neurotransmission associated with olanzapine-induced weight gain

Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses

A rating scale for depression

Melatonin in mood disorders

Melatonin receptors: molecular biology of a new family of G protein-coupled receptors

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

Lithium lengthens the circadian period of individual suprachiasmatic nucleus neurons.

Prediction of real-world functional disability in chronic mental disorders: a comparison of schizophrenia and bipolar disorder.

Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators.

A meta-analysis of the efficacy of second-generation antipsychotics.

P304

410-421

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BDI.12196

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24636483

http://www.w3.org/2001/XMLSchema#string

P921